- Home
- NEGG vs TVGN Comparison
NEGG vs TVGN Comparison
Compare NEGG & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEGG
- TVGN
- Stock Information
- Founded
- NEGG 2001
- TVGN 2020
- Country
- NEGG United States
- TVGN United States
- Employees
- NEGG N/A
- TVGN N/A
- Industry
- NEGG Other Specialty Stores
- TVGN Blank Checks
- Sector
- NEGG Consumer Discretionary
- TVGN Finance
- Exchange
- NEGG Nasdaq
- TVGN Nasdaq
- Market Cap
- NEGG 122.3M
- TVGN 193.1M
- IPO Year
- NEGG 2010
- TVGN N/A
- Fundamental
- Price
- NEGG $14.74
- TVGN $1.24
- Analyst Decision
- NEGG
- TVGN Strong Buy
- Analyst Count
- NEGG 0
- TVGN 1
- Target Price
- NEGG N/A
- TVGN $10.00
- AVG Volume (30 Days)
- NEGG 1.3M
- TVGN 734.5K
- Earning Date
- NEGG 04-28-2025
- TVGN 08-13-2025
- Dividend Yield
- NEGG N/A
- TVGN N/A
- EPS Growth
- NEGG N/A
- TVGN N/A
- EPS
- NEGG N/A
- TVGN N/A
- Revenue
- NEGG $1,235,576,000.00
- TVGN N/A
- Revenue This Year
- NEGG N/A
- TVGN N/A
- Revenue Next Year
- NEGG N/A
- TVGN N/A
- P/E Ratio
- NEGG N/A
- TVGN N/A
- Revenue Growth
- NEGG N/A
- TVGN N/A
- 52 Week Low
- NEGG $3.32
- TVGN $0.26
- 52 Week High
- NEGG $26.40
- TVGN $3.09
- Technical
- Relative Strength Index (RSI)
- NEGG 60.99
- TVGN 52.07
- Support Level
- NEGG $9.85
- TVGN $1.14
- Resistance Level
- NEGG $14.02
- TVGN $1.22
- Average True Range (ATR)
- NEGG 1.69
- TVGN 0.09
- MACD
- NEGG 0.02
- TVGN -0.01
- Stochastic Oscillator
- NEGG 63.85
- TVGN 44.12
About NEGG Newegg Commerce Inc.
Newegg Commerce Inc is an e-commerce company offering direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home, and gaming products and provides certain third-party logistics services globally. Geographically, it operates in United States, Canada, and Rest of World.
About TVGN Tevogen Bio Holdings Inc. Common Stock
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.